Cargando…
The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576039/ https://www.ncbi.nlm.nih.gov/pubmed/33241044 http://dx.doi.org/10.21037/atm-20-3170 |
| _version_ | 1783597933020577792 |
|---|---|
| author | Gridelli, Cesare Casaluce, Francesca |
| author_facet | Gridelli, Cesare Casaluce, Francesca |
| author_sort | Gridelli, Cesare |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7576039 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75760392020-11-24 The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not? Gridelli, Cesare Casaluce, Francesca Ann Transl Med Editorial Commentary AME Publishing Company 2020-09 /pmc/articles/PMC7576039/ /pubmed/33241044 http://dx.doi.org/10.21037/atm-20-3170 Text en 2020 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Gridelli, Cesare Casaluce, Francesca The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not? |
| title | The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not? |
| title_full | The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not? |
| title_fullStr | The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not? |
| title_full_unstemmed | The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not? |
| title_short | The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not? |
| title_sort | adjuvant regimen for resected egfr mutated patients: the “same-for-all-therapy” or not? |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576039/ https://www.ncbi.nlm.nih.gov/pubmed/33241044 http://dx.doi.org/10.21037/atm-20-3170 |
| work_keys_str_mv | AT gridellicesare theadjuvantregimenforresectedegfrmutatedpatientsthesameforalltherapyornot AT casalucefrancesca theadjuvantregimenforresectedegfrmutatedpatientsthesameforalltherapyornot AT gridellicesare adjuvantregimenforresectedegfrmutatedpatientsthesameforalltherapyornot AT casalucefrancesca adjuvantregimenforresectedegfrmutatedpatientsthesameforalltherapyornot |